The independent source for health policy research, polling, and news.
621-640 of 1,599 results
In its latest update to the Nursing Home Compare website, the government gave 1,638 homes its lowest star rating for staffing â one star on its five-star scale. Most were downgraded because payroll records reported no registered-nurse hours at all for at least four days.
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Erin Mershon of Stat News join KHNâs Julie Rovner to discuss the latest in news about the Trump administrationâs effort to overturn the Affordable Care Act, a historic hearing on âMedicare-for-allâ and the Kansas Supreme Courtâs ruling that the state constitution protects a womanâs right to abortion. Also, Rovner interviews KHNâs Carmen Heredia Rodriguez about the latest âBill of the Monthâ feature.
Under the rule that took effect this year, Medicare will lower payments for clinic visits performed at hospital-owned facilities to a rate that is equivalent to what it pays an independent doctor. Federal officials expect the move will save the government $380 million this year.
Whistleblower lawsuits accuse Tennessee chain of bilking millions from Medicare for unnecessary urine drug tests.
Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner to discuss the latest news about womenâs reproductive health policy and the latest skirmish in the debate over âMedicare-for-allâ: how hospitals should be paid.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Jennifer Haberkorn of the Los Angeles Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHNâs Julie Rovner to answer listener questions about the fate of the Affordable Care Act, âMedicare-for-allâ and how to talk about health care costs. Also, for extra credit, the panelists offer their favorite âextra creditâ stories of the week.
The plan by Sanders has drawn a lot of attention on the campaign trail and Capitol Hill. Â
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHNâs Julie Rovner to discuss the latest version of a âMedicare-for-allâ bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid â but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
Older adults â and their families â often find it challenging and stressful to find the best facility. And they often end up in the wrong spot, new research shows.
What to know about PBMs and rebates ahead of the Senate drug price hearing on â you guessed it â PBMs.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Beneficiaries pay 25 percent of the price of their brand-name drugs until they reach $5,100 in out-of-pocket costs. After that, their obligation drops to 5 percent. But it never disappears.
Some plans are experimenting with the idea of closely tying hospital reimbursement rates to what Medicare pays. The approach could be a game changer in their effort to control health costs.
Medicare doesnât pay for an annual physical, but it does cover an annual wellness visit focused on preventing disease and disability by coming up with a âpersonalized prevention planâ for future medical issues. It is important to use the correct term when scheduling a doctorâs visit.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Well-known insurers are offering plans with lower premiums. But they could leave patients on the hook for unexpected costs.
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
© 2026 51ÊÓÆ”